3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase 1/2
3
Phase NA
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
21
Myelodysplastic Syndromes
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Leukemia
14
Multiple Myeloma
12
Lymphoma
11
Leukemia, Lymphocytic, Chronic, B-Cell
11
Hodgkin Disease
11
Lymphoma, Non-Hodgkin
10
Leukemia, Myeloid, Chronic-Phase
8
Primary Myelofibrosis
7
Neoplasms, Plasma Cell
7
Myeloproliferative Disorders
7
Lymphoma, Mantle-Cell
7
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myelomonocytic, Chronic
7
Congenital Abnormalities
7
Lymphoma, Follicular
6
Leukemia, Myeloid, Accelerated Phase
6
Hematologic Neoplasms
6
Blast Crisis
6
Sezary Syndrome
5
Mycosis Fungoides
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Burkitt Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, T-Cell, Cutaneous
4
Interventions
Cyclophosphamide
5
fludarabine
3
Clofarabine
3
thymoglobulin
2
fludarabine phosphate
2
Vorinostat
2
Polymerase Chain Reaction
2
Methotrexate
2
Isotretinoin
2
Gemtuzumab
2
Flow Cytometry
2
Busulfan
2
Azacitidine
2
Antilymphocyte Serum
2
tipifarnib
1
ruxolitinib
1
merphos
1
imetelstat
1
hydrocortisone hemisuccinate
1
cc-486
1
Whole-Body Irradiation
1
Topotecan
1
Thiotepa
1
Tacrolimus
1
Spinal Puncture
1
Specimen Handling
1
Radioimmunotherapy
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Mycophenolic Acid
1
MK 2206
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Myelomonocytic, Juvenile
×
Tacrolimus
×
Clear all
NCT00669890
2015-04-22
High Risk
New York Medical College
Phase 1
Terminated
12 enrolled